Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 1 hour 7 min ago

Catalyst Pharmaceuticals Appoints David D. Muth, Executive Vice President, Chief Commercial Officer

Mon, 01/05/2015 - 23:56
CORAL GABLES, Fla., Jan. 5, 2015 -- (Healthcare Sales & Marketing Network) -- Catalyst Pharmaceutical Partners, Inc. (Catalyst Pharmaceuticals) (CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people wi...
Biopharmaceuticals, Personnel
Catalyst Pharmaceutical, Firdapse

GlySens Incorporated Secures $12M Series C Investment

Mon, 01/05/2015 - 23:51
Proceeds dedicated to advanced product commercialization steps SAN DIEGO, Jan. 5, 2015 -- (Healthcare Sales & Marketing Network) -- GlySens Incorporated announced today that it has closed a $12 million dollar Series C investment round, which included p...
Devices, Endocrinology, Venture Capital
GlySens, continuous glucose monitoring system

Aduro Biotech Closes $51.4 Million Series D Financing

Mon, 01/05/2015 - 13:12
Investment for Expansion of Research and Clinical Development of Aduro’s Immuno-Oncology Technology Platforms BERKELEY, Calif.--(Healthcare Sales & Marketing Network)--Aduro Biotech, Inc., a clinical-stage immuno-oncology company, today announced the cl...
Biopharmaceuticals, Oncology, Venture Capital
Aduro Biotech

Stereotaxis Receives FDA Clearance of Vdrive(R) With V-CAS(TM) System Along With Regulatory Approval of Odyssey(R) System in Japan

Mon, 01/05/2015 - 13:05
ST. LOUIS, Jan. 5, 2015 -- (Healthcare Sales & Marketing Network) -- Stereotaxis, Inc. (STXS) announced today that it has received 510(k) clearance by the Food and Drug Administration (FDA) for its Vdrive(R) with V-CAS(TM) Catheter Advancement System in th...
Devices, Cardiology, Regulatory
Stereotaxis, Vdrive , V-CAS , Catheter Advancement System

CardioFocus partners with Japan Lifeline for distribution of the HeartLight Laser Balloon to treat Atrial Fibrillation

Mon, 01/05/2015 - 12:58
Massachusetts company taps Japan EP market leader to introduce proprietary technology MARLBOROUGH, Mass., Jan. 5, 2015 -- (Healthcare Sales & Marketing Network) -- CardioFocus, Inc., developer of the HeartLight® Endoscopic Ablation System for the t...
Devices, Cardiology, Distribution
CardioFocus, Japan Lifeline Co, HeartLight, Endoscopic Ablation

Exact Sciences: Additional Update on CMS Reimbursement for Cologuard(R)

Fri, 01/02/2015 - 12:45
MADISON, Wis.--(Healthcare Sales & Marketing Network)--Exact Sciences Corp. (EXAS) today announced that the Centers for Medicare and Medicaid Services (CMS) has published an updated 2015 Clinical Laboratory Fee Schedule, which includes reimbursement for Ex...
Diagnostics, Reimbursement
Exact Sciences, Cologuard, colon cancer

Lightpoint Medical Raises £2 Million in Series A Funding Round

Tue, 12/30/2014 - 14:10
RICKMANSWORTH, England, December 30, 2014 -- (Healthcare Sales & Marketing Network) --Lightpoint Medical, a developer of innovative surgical imaging technologies, announced today that the company has raised £2 million ($3.1 million) in a Series A fi...
Devices, Venture Capital
Lightpoint Medical, LightPath, EnLight , Cerenkov Luminescence

BioTime Appoints Adi Mohanty Chief Operating Officer

Mon, 12/29/2014 - 13:45
Executive Brings Proven Leadership in Biopharmaceutical Product Development and Commercialization to BioTime ALAMEDA, Calif.--(Healthcare Sales & Marketing Network)--BioTime, Inc. (NYSE MKT:BTX), a leader in developing pluripotent stem-cell therapies an...
Regenerative Medicine, Personnel
BioTime

Jean Boulle Group Reports Successful First Clinical Trial Implant of the Tendyne Transcatheter Mitral Valve

Mon, 12/29/2014 - 13:26
LUXEMBOURG, December 29, 2014 -- (Healthcare Sales & Marketing Network) --Boulle Medtech Ltd, a Jean Boulle Group company focusing on medical technology and a founding investor of Tendyne Holdings, Inc. ("Tendyne"), is pleased to announce that t...
Devices, Interventional Cardiology
Jean Boulle Group, Boulle Medtech, Tendyne, Transcatheter Mitral Valve Implant

Roche receives FDA Emergency Use Authorization for the LightMix(R) Ebola Zaire rRT-PCR Test

Mon, 12/29/2014 - 13:14
PLEASANTON, Calif., Dec. 29, 2014 -- (Healthcare Sales & Marketing Network) -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has provided an Emergency Use Authorization (EUA) for the LightMix® Ebol...
Diagnostics
Roche, LightMix Ebola Zair, Ebola

Actavis and Adamas Announce FDA Approval of Namzaric(TM), a Fixed-Dose Combination of Memantine Extended-Release and Donepezil Hydrochloride

Wed, 12/24/2014 - 14:57
Indicated for Treatment of Moderate to Severe Alzheimer's Disease DUBLIN and EMERYVILLE, Calif., Dec. 24, 2014 -- (Healthcare Sales & Marketing Network) -- Actavis plc (ACT) and Adamas Pharmaceuticals Inc. (ADMS) today announced that the U.S. Food and ...
Biopharmaceuticals, Neurology, FDA
Actavis , Adamas Pharmaceuticals, Namzaric, memantine, donepezil, Alzheimer's

Echo Therapeutics Announces Scott W. Hollander as President and Chief Executive Officer

Tue, 12/23/2014 - 15:20
PHILADELPHIA, Dec. 23, 2014 -- (Healthcare Sales & Marketing Network) -- Echo Therapeutics, Inc. (ECTE), a medical device company focused on skin permeation, continuous glucose monitoring and associated technologies, today announced that Scott W. Hollande...
Devices, Monitoring, Personnel
Echo Therapeutics, Symphony CGM, continuous glucose monitoring

HeartFlow Names New General Counsel to Executive Team

Tue, 12/23/2014 - 15:13
REDWOOD CITY, Calif.--(Healthcare Sales & Marketing Network)--HeartFlow Inc., a pioneer in personalized medical technology for cardiovascular disease, has appointed Noemi C. (“Nicky”) Espinosa, as general counsel. Espinosa brings to HeartFlow 30 years of e...
Devices, Cardiology, Personnel
HeartFlow Inc,

Personalized Cancer Vaccine Moves to Phase IIb Trial at Leading U.S. Cancer Hospitals

Tue, 12/23/2014 - 15:02
U.S. Federal Drug Administration (FDA) Approves Randomized Trial of Elios Therapeutics' Immunotherapy Treatment for Stage III and IV (resected) Melanoma Patients AUSTIN, Texas, Dec. 23, 2014 -- (Healthcare Sales & Marketing Network) - Elios Therapeutic...
Biopharmaceuticals, Oncology
Elios Therapeutics, personalized vaccine, melanoma vaccine, melanoma

ZOLL Announces Definitive Agreement to Acquire Advanced Circulatory Systems, Inc.

Mon, 12/22/2014 - 17:56
CHELMSFORD, Mass.--(Healthcare Sales & Marketing Network)--ZOLL® Medical Corporation, a manufacturer of medical devices and related software solutions, today announced that it has reached a definitive agreement to acquire Advanced Circulatory Systems, ...
Devices, Cardiology, Mergers & Acquisitions
ZOLL Medical, Advanced Circulatory Systems, Intrathoracic Pressure Regulation

NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis

Mon, 12/22/2014 - 17:53
First-ever clearance of its kind in the US creates an important new option for patients and providers to perform home hemodialysis overnight while sleeping LAWRENCE, Mass., Dec. 22, 2014 -- (Healthcare Sales & Marketing Network) -- NxStage Medical, Inc...
Devices, FDA
NxStage Medical, hemodialysis

Hansen Medical Announces Key Developments in Global Expansion Strategy

Fri, 12/19/2014 - 15:25
Company Signs Exclusive Distribution Agreement With AB Medica s.p.a.; First Magellan(TM) Robotic System Installation Completed in Middle East Region MOUNTAIN VIEW, CA--(Healthcare Sales & Marketing Network) - Hansen Medical, Inc. (NASDAQ: HNSN), a globa...
Devices, Interventional, Distribution
Hansen Medical, Magellan, Sensei, Robotic Catheter

Merck Begins Tender Offer to Acquire Cubist

Fri, 12/19/2014 - 15:18
KENILWORTH, N.J.--(Healthcare Sales & Marketing Network)--Merck (MRK), known as MSD outside the United States and Canada, is commencing today, through a subsidiary, a cash tender to purchase all outstanding shares of common stock of Cubist Pharmaceuticals,...
Biopharmaceuticals, Mergers & Acquisitions
Merck, Cubist Pharmaceuticals

Scioderm, Inc. Closes $20 Million Series B Round of Financing

Thu, 12/18/2014 - 13:25
Funds will be used to complete the clinical development program for ZorblisaTM DURHAM, N.C., Dec. 18, 2014 -- (Healthcare Sales & Marketing Network) -- Scioderm, Inc., today announced it raised $20 million in a Series B financing round led by Redmile G...
Biopharmaceuticals, Dermatology, Venture Capital
Scioderm, Zorblisa, Epidermolysis Bullosa

Elekta Flexitron brachytherapy treatment delivery available in China

Thu, 12/18/2014 - 13:21
China Food and Drug Administration (CFDA) approves cancer treatment system BEIJING, Dec. 18, 2014 -- (Healthcare Sales & Marketing Network) -- Elekta (EKTA-B.ST) announces that the China Food and Drug Administration (CFDA) has approved Elekta's Flexitr...
Devices, Oncology, Regulatory
Elekta, Flexitron, brachytherapy, radiotherapy

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong